1-ethyl-2-benzimidazolinone has been researched along with Disease Models, Animal in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Ariwodola, OJ; Butler, TR; Chappell, AM; Rau, AR; Weiner, JL | 1 |
Bonci, A; Bowers, MS; Chang, SJ; Chen, BT; Cho, SL; Hopf, FW; Martin, M; Seif, T; Tye, K | 1 |
Becker, HC; Chandler, LJ; Mulholland, PJ; Woodward, JJ | 1 |
Anderson, NJ; Slough, S; Watson, WP | 1 |
Cuthbert, AW | 1 |
6 other study(ies) available for 1-ethyl-2-benzimidazolinone and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Increased Basolateral Amygdala Pyramidal Cell Excitability May Contribute to the Anxiogenic Phenotype Induced by Chronic Early-Life Stress.
Topics: Action Potentials; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Basolateral Nuclear Complex; Benzimidazoles; Calcium Channel Agonists; Disease Models, Animal; Germinal Center Kinases; In Vitro Techniques; Male; Microinjections; Patch-Clamp Techniques; Protein Serine-Threonine Kinases; Pyramidal Cells; Rats; Rats, Long-Evans; Small-Conductance Calcium-Activated Potassium Channels; Social Isolation; Stress, Psychological | 2015 |
Reduced nucleus accumbens SK channel activity enhances alcohol seeking during abstinence.
Topics: Action Potentials; Analysis of Variance; Animals; Apamin; Behavior, Animal; Benzimidazoles; Calcium Channel Agonists; Central Nervous System Depressants; Conditioning, Operant; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Food Preferences; Germinal Center Kinases; In Vitro Techniques; Male; Neurons; Nucleus Accumbens; Potassium Channels, Calcium-Activated; Protein Serine-Threonine Kinases; Rats; Rats, Wistar; Reinforcement Schedule; Self Administration; Small-Conductance Calcium-Activated Potassium Channels; Sucrose; Sweetening Agents | 2010 |
Small conductance calcium-activated potassium type 2 channels regulate alcohol-associated plasticity of glutamatergic synapses.
Topics: Analysis of Variance; Animals; Animals, Newborn; Benzimidazoles; Calcium; Calcium Channel Agonists; Central Nervous System Depressants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Ethanol; Excitatory Postsynaptic Potentials; Gene Expression Regulation; Glutamic Acid; Hippocampus; Male; Mice; Neuronal Plasticity; Neurons; Organ Culture Techniques; Patch-Clamp Techniques; Propidium; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Small-Conductance Calcium-Activated Potassium Channels; Substance Withdrawal Syndrome; Synapses; Time Factors | 2011 |
In vivo characterisation of the small-conductance KCa (SK) channel activator 1-ethyl-2-benzimidazolinone (1-EBIO) as a potential anticonvulsant.
Topics: Animals; Anticonvulsants; Benzimidazoles; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Levetiracetam; Male; Mice; Motor Activity; Pentylenetetrazole; Phenytoin; Pilocarpine; Piracetam; Seizures; Sensory Thresholds; Small-Conductance Calcium-Activated Potassium Channels | 2006 |
Assessment of CFTR chloride channel openers in intact normal and cystic fibrosis murine epithelia.
Topics: Animals; Benzimidazoles; Calcium Channel Blockers; Colforsin; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Disease Models, Animal; Electric Conductivity; Intestinal Mucosa; Mice | 2001 |